Nifty
Sensex
:
:
15161.00
51327.62
179.00 (1.19%)
676.16 (1.33%)

Pharmaceuticals & Drugs - API

Rating :
64/99

BSE: 532488 | NSE: DIVISLAB

3480.05
24-Feb-2021
  • Open
  • High
  • Low
  • Previous Close
  •  3496.90
  •  3509.80
  •  3412.40
  •  3448.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  409153
  •  14210.23
  •  3914.95
  •  1626.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 92,465.36
  • 49.31
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 92,150.71
  • 0.46%
  • 11.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.95%
  • 1.41%
  • 8.71%
  • FII
  • DII
  • Others
  • 20.37%
  • 16.55%
  • 1.01%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.15
  • 7.39
  • 11.50

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.79
  • 5.15
  • 7.62

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.36
  • 4.10
  • 16.21

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.90
  • 31.95
  • 42.24

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.76
  • 6.74
  • 7.50

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.98
  • 23.50
  • 27.67

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
1,701.44
1,396.26
21.86%
1,749.30
1,445.57
21.01%
1,730.47
1,162.88
48.81%
1,389.71
1,267.13
9.67%
Expenses
1,010.23
902.36
11.95%
1,008.16
955.01
5.57%
1,030.39
775.74
32.83%
945.26
850.73
11.11%
EBITDA
691.21
493.90
39.95%
741.14
490.56
51.08%
700.08
387.14
80.83%
444.45
416.40
6.74%
EBIDTM
40.63%
35.37%
42.37%
33.94%
40.46%
33.29%
14.01%
14.01%
Other Income
19.32
41.67
-53.64%
13.64
47.03
-71.00%
17.33
30.32
-42.84%
76.73
40.84
87.88%
Interest
0.27
1.55
-82.58%
0.16
3.79
-95.78%
0.23
0.32
-28.12%
0.44
0.10
340.00%
Depreciation
68.18
46.70
46.00%
61.13
45.93
33.09%
56.20
43.83
28.22%
49.78
42.37
17.49%
PBT
642.08
487.32
31.76%
693.49
487.87
42.15%
660.98
373.31
77.06%
470.96
414.77
13.55%
Tax
171.46
128.23
33.71%
173.90
131.09
32.66%
168.92
100.87
67.46%
82.73
122.80
-32.63%
PAT
470.62
359.09
31.06%
519.59
356.78
45.63%
492.06
272.44
80.61%
388.23
291.97
32.97%
PATM
27.66%
25.72%
29.70%
24.68%
28.43%
23.43%
7.11%
7.11%
EPS
17.73
13.53
31.04%
19.57
13.44
45.61%
18.54
10.26
80.70%
28.29
28.29
0.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
6,570.92
5,394.42
4,946.26
3,891.49
4,064.34
3,776.36
3,114.94
2,532.14
2,144.84
1,863.87
1,316.54
Net Sales Growth
24.64%
9.06%
27.10%
-4.25%
7.63%
21.23%
23.02%
18.06%
15.07%
41.57%
 
Cost Of Goods Sold
6,386.81
2,108.54
1,825.22
1,534.06
1,534.00
1,505.32
1,213.24
914.15
798.63
761.64
512.82
Gross Profit
184.11
3,285.88
3,121.04
2,357.43
2,530.34
2,271.04
1,901.70
1,617.99
1,346.21
1,102.23
803.72
GP Margin
2.80%
60.91%
63.10%
60.58%
62.26%
60.14%
61.05%
63.90%
62.77%
59.14%
61.05%
Total Expenditure
3,994.04
3,571.21
3,073.24
2,628.74
2,617.20
2,358.04
1,948.69
1,516.76
1,328.87
1,172.59
815.64
Power & Fuel Cost
-
280.73
248.78
228.73
198.80
180.34
170.82
147.40
131.02
86.13
62.65
% Of Sales
-
5.20%
5.03%
5.88%
4.89%
4.78%
5.48%
5.82%
6.11%
4.62%
4.76%
Employee Cost
-
621.05
542.27
456.06
499.90
361.19
290.42
232.46
197.72
150.85
117.23
% Of Sales
-
11.51%
10.96%
11.72%
12.30%
9.56%
9.32%
9.18%
9.22%
8.09%
8.90%
Manufacturing Exp.
-
258.91
212.96
182.67
169.15
169.42
147.24
121.10
104.85
86.61
65.13
% Of Sales
-
4.80%
4.31%
4.69%
4.16%
4.49%
4.73%
4.78%
4.89%
4.65%
4.95%
General & Admin Exp.
-
148.62
105.30
139.33
88.22
73.91
63.85
51.74
44.15
32.47
27.57
% Of Sales
-
2.76%
2.13%
3.58%
2.17%
1.96%
2.05%
2.04%
2.06%
1.74%
2.09%
Selling & Distn. Exp.
-
85.36
73.08
64.02
67.48
56.04
51.93
44.22
51.29
53.63
29.80
% Of Sales
-
1.58%
1.48%
1.65%
1.66%
1.48%
1.67%
1.75%
2.39%
2.88%
2.26%
Miscellaneous Exp.
-
68.00
65.63
23.87
59.65
11.80
11.18
5.69
1.21
1.27
29.80
% Of Sales
-
1.26%
1.33%
0.61%
1.47%
0.31%
0.36%
0.22%
0.06%
0.07%
0.03%
EBITDA
2,576.88
1,823.21
1,873.02
1,262.75
1,447.14
1,418.32
1,166.25
1,015.38
815.97
691.28
500.90
EBITDA Margin
39.22%
33.80%
37.87%
32.45%
35.61%
37.56%
37.44%
40.10%
38.04%
37.09%
38.05%
Other Income
127.02
189.63
155.63
113.44
74.89
97.44
44.70
70.60
44.81
56.05
27.12
Interest
1.10
7.14
4.68
2.37
3.36
4.74
2.88
2.96
2.59
4.61
2.26
Depreciation
235.29
186.24
168.90
142.49
123.33
118.18
136.00
92.12
76.95
62.08
53.40
PBT
2,467.51
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
680.63
472.37
Tax
597.01
442.92
502.33
354.32
334.92
267.06
220.56
217.58
179.23
147.36
43.10
Tax Rate
24.19%
24.34%
27.08%
28.78%
24.00%
19.17%
20.57%
21.96%
22.94%
21.65%
9.12%
PAT
1,870.50
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
533.26
429.27
PAT before Minority Interest
1,870.50
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
533.26
429.27
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
28.47%
25.52%
27.35%
22.54%
26.09%
29.81%
27.34%
30.54%
28.07%
28.61%
32.61%
PAT Growth
46.10%
1.76%
54.24%
-17.30%
-5.81%
32.21%
10.11%
28.46%
12.89%
24.22%
 
EPS
70.45
51.85
50.95
33.03
39.94
42.40
32.07
29.13
22.67
20.09
16.17

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
7,309.92
6,957.15
5,924.80
5,357.39
4,293.31
3,495.36
2,963.35
2,500.60
2,131.52
1,797.48
Share Capital
53.09
53.09
53.09
53.09
53.09
26.55
26.55
26.55
26.55
26.52
Total Reserves
7,256.83
6,904.06
5,871.71
5,304.30
4,240.21
3,468.81
2,936.80
2,474.05
2,104.98
1,769.98
Non-Current Liabilities
294.57
991.38
1,768.91
1,411.75
85.17
841.57
650.05
469.75
71.35
67.39
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.18
Unsecured Loans
0.00
0.00
0.00
0.00
0.47
1.05
1.55
2.10
2.56
2.74
Long Term Provisions
20.52
772.54
1,577.26
1,288.92
11.57
714.30
533.49
388.43
1.65
2.82
Current Liabilities
1,820.53
846.75
653.42
659.45
519.50
775.53
627.41
554.45
553.78
409.90
Trade Payables
590.72
492.26
411.21
445.80
232.69
226.87
151.70
160.44
159.54
123.00
Other Current Liabilities
290.09
243.59
175.46
176.63
240.58
203.45
147.80
130.08
135.83
105.35
Short Term Borrowings
33.63
105.60
63.11
35.74
41.42
25.07
16.32
30.51
50.20
13.62
Short Term Provisions
906.09
5.30
3.64
1.28
4.81
320.14
311.58
233.42
208.21
167.92
Total Liabilities
9,425.02
8,795.28
8,347.13
7,428.59
4,897.98
5,112.46
4,240.81
3,524.80
2,756.65
2,274.77
Net Block
2,781.85
2,087.77
1,996.19
1,559.19
1,438.77
1,308.89
1,221.84
908.72
738.42
589.93
Gross Block
3,514.26
2,633.93
2,373.45
1,793.95
2,196.08
1,953.02
1,740.34
1,338.35
1,092.05
885.70
Accumulated Depreciation
732.41
546.16
377.26
234.76
757.32
644.13
518.50
429.63
353.64
295.77
Non Current Assets
3,851.49
4,145.23
3,812.01
3,418.08
1,870.93
2,340.06
1,984.45
1,660.69
1,005.71
734.07
Capital Work in Progress
919.69
491.91
119.76
443.57
263.91
218.18
144.48
303.41
181.58
103.72
Non Current Investment
0.01
547.26
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
144.50
1,012.93
1,688.23
1,406.48
162.44
812.63
618.03
448.49
83.68
38.20
Other Non Current Assets
5.44
5.36
7.82
8.83
5.80
0.35
0.09
0.07
1.63
1.60
Current Assets
5,573.53
4,650.05
4,535.12
4,010.51
3,027.04
2,772.40
2,256.35
1,864.11
1,750.95
1,540.71
Current Investments
971.35
1,398.34
1,889.28
1,630.72
802.85
733.00
501.88
407.81
477.04
525.64
Inventories
1,863.86
1,772.34
1,350.67
1,319.91
1,207.83
1,162.64
932.42
835.69
678.96
571.71
Sundry Debtors
1,413.35
1,163.37
1,014.36
900.92
880.92
741.64
723.70
512.00
495.08
365.23
Cash & Bank
122.63
115.26
112.46
78.70
73.43
65.22
40.51
40.89
30.94
17.67
Other Current Assets
1,202.34
142.20
124.98
20.67
62.01
69.89
57.85
67.71
68.93
60.46
Short Term Loans & Adv.
999.77
58.54
43.37
59.59
42.88
54.98
48.16
57.97
63.25
57.36
Net Current Assets
3,753.00
3,803.30
3,881.70
3,351.06
2,507.54
1,996.87
1,628.95
1,309.66
1,197.16
1,130.81
Total Assets
9,425.02
8,795.28
8,347.13
7,428.59
4,897.97
5,112.46
4,240.80
3,524.80
2,756.66
2,274.78

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
1,215.94
954.30
775.86
1,150.37
1,037.86
826.33
556.75
479.97
338.36
326.55
PBT
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
680.63
472.37
Adjustment
60.01
83.51
32.19
93.87
60.94
91.24
77.55
59.25
26.87
26.87
Changes in Working Capital
-218.30
-499.84
-219.11
-37.14
-155.03
-125.55
-298.39
-186.05
-242.47
-139.28
Cash after chg. in Working capital
1,661.17
1,438.74
1,044.41
1,452.07
1,298.75
1,037.76
770.07
654.44
465.03
359.97
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-445.23
-484.44
-268.55
-301.70
-260.89
-211.43
-213.32
-174.47
-126.68
-33.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-83.47
-685.40
-478.30
-1,139.60
-406.41
-520.84
-305.15
-254.54
-204.41
-221.31
Net Fixed Assets
-1,302.55
-632.52
-255.54
222.19
-288.75
-286.31
-242.98
-368.08
-284.15
-132.66
Net Investments
974.24
-56.30
-257.57
-826.05
-77.22
-231.12
-94.07
69.23
48.60
-86.61
Others
244.84
3.42
34.81
-535.74
-40.44
-3.41
31.90
44.31
31.14
-2.04
Cash from Financing Activity
-1,091.42
-245.94
-314.16
2.38
-631.12
-302.95
-248.50
-230.76
-131.11
-104.16
Net Cash Inflow / Outflow
41.05
22.96
-16.60
13.15
0.33
2.54
3.10
-5.33
2.84
1.09
Opening Cash & Equivalents
2.10
-20.86
-4.26
-17.41
17.62
15.09
11.99
17.32
14.48
13.39
Closing Cash & Equivalent
43.15
2.10
-20.86
-4.26
17.95
17.62
15.09
11.99
17.32
14.48

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
275.38
262.09
223.20
201.82
161.73
131.67
111.63
94.20
80.29
67.74
ROA
15.11%
15.78%
11.12%
17.21%
22.49%
18.21%
19.92%
19.17%
21.20%
20.77%
ROE
19.30%
21.00%
15.55%
21.98%
28.91%
26.37%
28.31%
25.99%
27.15%
25.94%
ROCE
25.36%
28.50%
21.68%
28.75%
35.57%
33.06%
36.04%
33.21%
34.20%
28.16%
Fixed Asset Turnover
1.75
1.98
1.88
2.06
1.83
1.70
1.66
1.78
1.90
1.55
Receivable days
87.17
80.35
89.33
79.19
77.83
85.12
88.42
85.08
83.45
80.71
Inventory Days
123.02
115.23
124.56
112.34
113.70
121.69
126.52
127.96
121.31
146.79
Payable days
54.82
52.21
60.15
47.14
35.06
33.55
36.16
42.47
42.66
63.49
Cash Conversion Cycle
155.38
143.37
153.75
144.39
156.47
173.26
178.78
170.58
162.09
164.00
Total Debt/Equity
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.03
0.01
Interest Cover
255.83
397.38
520.55
416.28
294.75
373.59
336.24
302.96
148.53
210.46

News Update:


  • Divi’s Laboratories to commence construction at unit-III Andhra Pradesh facility
    1st Dec 2020, 15:01 PM

    The operations are likely to commence within 12 to 18 months for 1st phase of the Project

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.